US Retail Sales Demonstrate Resilience Amid Ongoing Cost Pressures ING Analysis Tronox TROX Slides 256 as Selling Pressure Mounts 20260514 DeepMinds Demis Hassabis Named Early Investor in Anthropic as AI Influence Expands Fifth FITB Declines 127 Amid Market Weakness 20260519 Nvidia Surpasses Quarterly Projections as AI Chip Demand Fuels Record Revenue GigCapital9 GIX Flat at 989 Consolidation Continues 20260520 Judge Dismisses Trumps IRS Lawsuit Opening Door for Potential Settlement Banzai BNZI Q1 2026 Miss Should Investors Be Worried Front Row at Indy 500 Delivers Decisive Competitive and Financial Edge Analysis of 20182025 Data US April Payrolls Surge Above Expectations But Underlying Weakness Raises Concerns Mercury Achieves 52 Billion Valuation After 200M Funding Round Defying Fintech Downturn AIDriven Layoffs Market Reaction May Be Less Positive Than Expected Jamie Dimon Signals JPMorgan Chase Could Pursue 20 Billion Acquisition Spree Oil Markets Near Minimum Operating Levels in Asia Warns Carlyles Jeff Currie BMO Q1 2026 Earnings Strong EPS Beat Drives Optimism Amid Steady Performance LIXT Q4 2024 Earnings Biotech Reports Net Loss Stock Declines RRX Q1 2026 Earnings Earnings Beat on Solid Execution Amid Mixed Market Conditions Milestone Pharmaceuticals MIST Q1 2026 Earnings EPS Miss Deepens as ClinicalStage Biotech Navigates Development Path CBRE Q1 2026 Earnings Strong EPS Beat Amid Resilient Commercial Real Estate Market Golden Dome Missile Defense Concept Poses Critical Test for Defense Contractors AEVA Q1 2026 Earnings EPS Beat Driven by Cost Discipline Amid PreRevenue Stage ADUS Q1 2026 Earnings EPS Beats Estimates Despite Modest Stock Decline Main Street Capital Corporation MAIN Q1 2026 Earnings EPS Miss Weighs on Shares ALGM Q1 2026 Earnings EPS Beats Estimates Amid Modest Stock Gain Bowman Consulting Group Ltd BWMN Q1 2026 Earnings EPS Falls Sharply Short of Estimates Amid Challenging Quarter AVTX Q1 2026 Earnings Narrowed Loss Meets Expectations Amid Strategic Pivot GLUE Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Pipeline CTLP Q1 2026 Earnings EPS Misses Estimates by 50 Stock Unchanged